NCT01415752 2026-06-03Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell LymphomaEastern Cooperative Oncology GroupPhase 2 Active not recruiting373 enrolled 14 charts